# Tania Gulati

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tania-gulati/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32 |
| Field | Migraine and Headache Studies |
| h-index | 4 |
| i10-index | 1 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5043731679 |
| Works | 9 |

## Researcher papers

- [Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years](https://scholariq.org/papers/preventive-treatment-patterns-in-the-adult-migraine-population-an-observational/)
- [Characteristics of patients initiating treatment with baricitinib and outcomes at follow-up: analysis of BSRBR-RA Registry data](https://scholariq.org/papers/characteristics-of-patients-initiating-treatment-with-baricitinib-and-outcomes/)
- [Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus](https://scholariq.org/papers/secondary-metformin-monotherapy-failure-in-individuals-with-type-2-diabetes/)
- [Treatment Patterns, Healthcare Resource Utilization, and Direct Costs Among Patients Initiating Concomitant Use of a Calcitonin Gene-Related Peptide Monoclonal Antibody (CGRP mAb) and Novel Acute Medication in the United States](https://scholariq.org/papers/treatment-patterns-healthcare-resource-utilization-and-direct-costs-among/)
- [Adherence and Persistence among Patients with Migraine Initiating Concomitant Use of Self-Injectable Calcitonin Gene-related Peptide Monoclonal Antibody and Novel Acute Migraine Medications (P10-12.007)](https://scholariq.org/papers/adherence-and-persistence-among-patients-with-migraine-initiating-concomitant/)
- [Real-World Dose Escalation and Associated Direct Costs of Biologics in Management of Ulcerative Colitis: A Retrospective Database Study](https://scholariq.org/papers/real-world-dose-escalation-and-associated-direct-costs-of-biologics-in/)
- [2352-PUB: Level of Glycemic Control in Type 2 Diabetes (T2D) Patients with Established Cardiovascular Disease (eCVD) or Chronic Kidney Disease (CKD) Prescribed an SGLT2i](https://scholariq.org/papers/2352-pub-level-of-glycemic-control-in-type-2-diabetes-t2d-patients-with/)
- [1637-P: Role of Initial Combination Therapy on Goal Attainment among Patients with Type 2 Diabetes with High HbA1c](https://scholariq.org/papers/1637-p-role-of-initial-combination-therapy-on-goal-attainment-among-patients/)
- [090 Frequency of migraine and the use of preventive medication in a UK primary care population](https://scholariq.org/papers/090-frequency-of-migraine-and-the-use-of-preventive-medication-in-a-uk-primary/)

## Researcher topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.